Table 4.
Author(s) & study aim | Study population & design | Study outcomes & implications |
---|---|---|
Alam et al.
72
- Compare diagnostic capability of CCM against IENFD & QST in patients with DSPN |
N = 88 n = 30 T1D, -DSPN M = 38.8 ± 12.5 n = 31 T1D, +DSPN M = 53.3 ± 11.9 n = 27 HCs M = 41.0 ± 14.9 Cross-sectional |
• AUC for CNFD was 0.81 with an optimal cutoff of 25.0
no/mm2, sensitivity of 77% & specificity
of 79% for diagnosis of DSPN • AUC for CNBD was 0.67 with an optimal cutoff of 36.5 no/mm2, sensitivity of 58% & specificity of 79% for diagnosis of DSPN • AUC for CNFL was 0.74 with an optimal cutoff of 16.8 mm/mm2, sensitivity of 61% & specificity of 80% for diagnosis of DSPN • AUC for IENFD was 0.73 with an optimal cutoff of 4.5 fibers/mm, sensitivity of 61% & specificity of 86% for diagnosis of DSPN • CCM is a non-invasive method, with respectable performance, to identify small nerve fiber pathology & diagnose DSPN |
Al-Fahdawi et al.
92
-Propose a robust, fast & fully automatic nerve segmentation & morphometric parameter quantification system for CCM images |
N = 20, 498
images n = 12 +DM M = 58 ± 10 yrs/age n = 4 -DPN n = 5 mild DPN n = 3 moderate DPN n = 8 HCs M = 54 ± 7 yrs/age Cross-sectional |
• For manually & automatically traced nerves, average
tortuosity was 8.27 ± 7.18 & 6.7 ± 5.60, respectively,
for controls; 20.11 ± 19.04 & 13.9 ± 12.79,
respectively, for -DPN group; 37.52 ± 36.41 & 29.32 ±
28.36, respectively, for mild DPN group; & 40.45 ± 39.30
& 51.76 ± 50.64, respectively, for moderate DPN group
• For manually & automatically traced nerves, average nerve length was 60.92 mm & 61.22 mm, respectively, for controls; 58.49 mm & 56.87 mm, respectively, for -DPN group; 57.08 mm & 56.87 mm, respectively, for mild DPN group; & 57.08 mm & 56.63 mm, respectively, for moderate DPN group • Across manually & automatically traced nerve methods, comparable results found for average nerve length values although average tortuosity values appear less consistent • Both manually & automatically traced nerve methods reveal increasing nerve tortuosity & decreased nerve length according to severity of DPN |
Al Rashah et al.
93
-Assess repeatability CNM rate measurement in individuals with or without neuropathy |
N = 14 M = 51.9 ± 13.8 yrs/age n = 5 +DM, +DN n = 5 +DM, -DN n = 4 HCs Longitudinal (3-week FU) |
• Within & between observer repeatability of CNM within
4 different zones & CNM rate of the vertical section of
the wide-field montage was outstanding with ICCs of 0.99
& 0.99, respectively • Repeatability of CNM rate of the vertical section of the wide-field montage within observers, when using semi-automated & fully automated image montaging software, was also outstanding with an ICC of 0.96 • With a laser-scanning CCM, CNM rate measurement shows impressive repeatability for within & between observers & when using manual, semi-automated, & fully automated image montaging |
Azmi, et al.
73
-Assess whether baseline and follow-up measures of neuropathy, particularly small-fiber neuropathy, relate to changes in glucose tolerance over 3 yrs |
N = 47 n = 30 IGT M = 60 ± 2.1 yrs/age n = 17 Controls M = 62.3 ± 1.8 yrs/age Longitudinal (3-year FU) |
• FU: 10 IGT participants developed T2D & had
significantly lower CNFD, CNBD, & CNFL at baseline
compared to controls; IGT participants who developed T2D
also had a further significant reduction in CNFL, IENFD,
& MDL • FU: 15 participants had no change in IGT status & 5 participants returned to NGT with no significant baseline abnormality on CCM or IENFD • FU: IGT participants (n=15) showed a significant decrease in IENFD but no change in CCM • FU: Participants returning to NGT (n=5) showed a significant increase in CNFD, CNBD, & CNFL, but a significant decrease in IENFD • CCM may be an early marker of small-fiber neuropathy & allow for risk stratification of individuals with IGT likely to progress to T2D |
Batawi et al.
94
- Study SCNP parameters by IVCCM using a new software technology |
N = 29 M = 46 ± 20 yrs/age n = 22 +DM Cross-sectional |
• Inter-operator reproducibility & intra-operator
reproducibility ICCs, respectively, were: (1) NFLD 0.97
& 0.97; (2) NFL 0.97 & 0.97; (3) NF 0.90 & 0.93;
(4) NT 0.97 & 0.96; (5) NBi 0.83 & 0.87; (6) NBr
0.81 & 0.87; (7) BD 0.92 & 0.95; (8) NBe 0.95 &
0.97; (9) NFT 0.73 & 0.88 • Semi-automated corneal nerve analysis showed excellent precision or reproducibility for evaluation of SCNP parameters with CCM |
Brines et al.
95
-Using an automated methodology, compare sensitivity & specificity of NFD, NBD, NFL, & NFA for discriminating participants with neuropathy from NCs |
N = 129 n = 21 -DN M = 37.1 ± 16.5 yrs/age n = 21 mild DN M = 55.9 ± 11.0 yrs/age n = 19 moderate DN M = 59.0 ±11.3 yrs/age n = 20 severe DN M = 57.0 ± 14.6 yrs/age n = 48 NCs M = 46.2 ± 16.9 yrs/age Cross-sectional |
• In participants with no or mild DN, relative to NCs,
respectively, AUROC curves for NFD, NFB, NFL, NFA WxL, &
NFA FIJI (≥0.70 – <0.85 range) were fair to
good • In participants with moderate to severe DN, relative to NCs, respectively, AUROC curves for NFD, NBD, NFL, & NFA WxL (>0.80 – <1.0 range) were good to excellent • With DM participants collapsed into 1 group, cutoff points for discrimination of participants having DN from NCs were calculated from ROC curves; DM group cut point for NFD was 23.4 fibers/mm2 with a sensitivity of 90% & specificity of 69%; DM group cut point for NBD was 23.4 branches/mm2 with a sensitivity of 86% & specificity of 71%; DM group cut point for NFL was 12.3 mm/mm2 with a sensitivity of 96% & specificity of 68%; DM group cut point for NFA FIJI was 19,128 μm2/mm2 with a sensitivity of 94% & specificity of 59% • Overall, automated methodology revealed good to excellent diagnostic performance in detecting moderate to severe DN & impressive ability to identify true positives for DN in DM participants |
Chen, et al.
96
-Determine the diagnostic performance of CCM (manual & automated methods) & IENFD for DSPN |
N = 89 n = 17 T1D, +DSPN M = 59 ± 11 yrs/age n = 46 T1D, -DSPN M = 44 ± 13 yrs/age n = 26 CG M = 44 ± 15 yrs/age Cross-sectional |
• AUCs: CNFD manual 0.82 & automated 0.80; CNFD manual
S/S = 76% at EERP; CNFD manual S/S = 82%/71% at threshold of
24.0 (M ± 2 SDs); CNFD automated S/S = 70% at EERP; CNFD
automated S/S = 60%/83% at threshold of 15.5 (M ± 2
SDs) • AUCs: CNFL manual 0.70 & automated 0.77; CNFL manual S/S = 71% at EERP; CNFL manual S/S = 59%/74% at threshold of 16.5 (M ± 2 SDs); CNFL automated S/S = 70% at EERP; CNFL automated S/S = 59%/80% at threshold of 10.5 (M ± 2 SDs) • AUCs: CNBD manual 0.59 & automated 0.70; CNBD manual S/S = 53% at EERP; CNBD manual S/S = 17%/96% at threshold of 15.0 (M ± 2 SDs); CNBD automated S/S = 59% at EERP; CNBD automated S/S = 29%/98% at threshold of 4.0 (M ± 2 SDs) • AUC of IENFD = 0.66; IENFD S/S = 65% at EERP; IENFD S/S = 53%/76% at threshold of 3.3 (M ± 2 SDs) • Overall, performance between CCM (manual & automated) & IENFD comparable |
Chen, et al.
97
-Evaluate an automated software tool for nerve-fiber detection & quantification in CCM images, combining sensitive nerve-fiber detection with morphological descriptors |
N = 176; 888
images n = 63 T1D, +DSPN n = 29 T1D, -DSPN n = 84 Controls Cross-sectional |
• AUCs of ACNFD, ACNFL, & ACNBD were 0.76, 0.76, 0.68,
respectively; ACNFD S/S = 65%, ACNFL S/S = 62%, & ACNBD
S/S = 58% at EEP for discriminating +DSPN &
-DSPN • AUCs of MCFND, MCNFL, & ACNBD were 0.79, 0.71, & 0.61, respectively; MCNFD S/S = 72%, MCNFL S/S = 66% & MCNBD S/S = 59% at EEP for discriminating +DSPN & -DSPN • AUCs of combined CCM automated & manual features were 0.74 & 0.78, respectively; CCM automated S/S = 71%; CCM manual S/S = 68% for discriminating +DSPN & -DSPN • Performance of automated quantification compared to manual quantification of corneal nerves in CCM images is relatively equivalent • Automated quantification provides a sensitive tool for identification of DSPN while improving speed & repeatability |
Chen, et al.
98
-Evaluate the performance of previously established CCM parameters to a novel automated measure of corneal nerve complexity (ACNFrD) |
N = 176 n = 84 AMCs M = 46 ± 15 yrs/age n = 29 T1D, +DSPN M = 63 ± 12 yrs/age n = 63 T1D, -DSPN M = 44 ± 15 yrs/age Cross-sectional |
• AUROC curve for ACNFD was 0.77, ACNFL was 0.74, ACNBD was
0.69, & ACNFrD was 0.74; ACNFD S/S = 65% at EER; S/S =
63%/79% at threshold of 15.1(M ± 2 SDs); ACNFL S/S = 62% at
EER; S/S = 62%/83% at threshold of 10.2 (M ± 2 SDs); ACNBD
S/S = 58% at EER; S/S = 24%/98% at threshold of 3.3 (M ± 2
SDs); ACNFrD S/S = 65% at EER; S/S = 61%/78% at threshold of
1.45 (M ± 2 SDs) • AUROC curves were 0.79 for MCNFD, 0.71 for MCNFL, & 0.61 for MCNBD; MCNFD S/S = 72% at EER; S/S = 79%/71% at threshold of 23.8 (M ± 2 SDs); MCNFL S/S = 65% at EER; S/S = 55%/86% at threshold of 14.9 (M ± 2 SDs); MCNBD S/S = 59% at EER; S/S = 17%/96% at threshold of 13.8 (M ± 2 SDs) • ACNFrD performance comparable to automated & manual CNFD, CNBD, & CNFL in diagnosing patients with +DSPN or -DSPN • Automated & manual methods show good equivalency in accuracy |
Dehghani et al.
99
- Determine alterations in CSNP over 4 yrs using IVCCM |
N = 108 T1D, -PN (baseline) M = 43.9 ± 15.7 age/yrs (baseline) Longitudinal |
• At 4-yr FU, mean CNFD (no./mm2, 19.6 ± 6.9) was
marginally significantly increased compared to baseline
(18.3 ± 7.1) • At 4-yr FU, mean CNBD (no./mm2, 29.1 ± 19.6) was significantly increased relative to baseline (24.2 ± 17.4) • At 4-yr FU, mean CNFL (mm/mm2, 16.3 ± 3.7) did not significantly change from baseline (16.0 ± 3.8) • IVCCM may be useful for monitoring subclinical alterations in CSNP in T1D |
Dell’Omo, et al.
100
-Measure the thickness & length of corneal nerves & peri-papillary RNFL thickness in patients recently diagnosed with T2D |
N = 44 n = 22 new onset T2D M = 50.6 ± 6.74 age/yrs n = 22 HCs M = 50.8 ± 4.26 age/yrs Cross-sectional |
• Evaluated by CCM, CNT & CNL were significantly lower
in participants with new onset T2D than
controls • Using SD-OCT, RNFL thickness in temporal quadrant was significantly lower in patients with T2D relative to controls • ICC values for intra-observer and inter-observer repeatability for CNT were 0.76 & 0.78 & for CNL 0.71 & 0.74, respectively • Reductions observed in CNL, CNT, & RNFL thickness suggest that CCM & SD-OCT may detect early markers of neuropathy in patients recently diagnosed with T2D • ICC values revealed good reliability |
Dhage, et al.
75
-Assess the longitudinal utility of different measures of neuropathy in patients with diabetes |
N = 38 n = 19 +DM M = 52.5 ± 14.7 yrs/age (baseline) n = 19 HCs M = 47.4 ± 14.2 yrs/age (baseline) Longitudinal cohort study (MFU = 6.5 yrs) |
• At baseline, CNFD, CNBD & CNFL significantly reduced
in DM participants vs. controls • Compared to baseline, CNFD, CNBD & CNFL significantly decreased in DM participants at FU • At baseline, NSP & NDS scores significantly higher & IENFD significantly lower in DM participants vs. controls • Compared to baseline, NSP & NDS scores significantly increased & IENFD significantly decreased in DM participants at FU • Change in CNFD, CNBD, & CNFL significantly correlated with change in IENFD • CCM, a rapid, non-invasive & reproducible ophthalmic imaging technique to objectively quantify small-fiber damage in DN, was found to longitudinally identify progressive nerve damage |
Edwards et al.
101
-Demonstrate DN development & progression in T1D individuals |
N = 38, T1D, -DN (baseline) Longitudinal cohort study (4-yr FU) |
• CNFL identified 7 participants who had unfavorable corneal
nerve changes from baseline to 4-yr FU • CNFL, relative to PNCV, CST, WST, VPT, NDS, & monofilament testing, consistently performed better • CNFL revealed the earliest, most sustained, & highest proportion of abnormal parameters indicative of PN development |
Ferdousi et al.
102
- Identify longitudinal CNM changes in CC & IW relative to other DN measures |
N = 36 n = 19 age-matched HCs M = 49.47 ± 13.25 yrs/age n = 30 +DM M = 54.08 ± 15.86 yrs/age (baseline) n = 21 T1D n = 9 T2D Longitudinal cohort MFU = 3.6 ± 1.3 |
• In participants with DM, CNBD (mm/mm2) &
CNFL (mm/mm2) were significantly reduced from
baseline (57.72 ± 30.08; 21.77 ± 5.19, respectively) to FU
(44.04 ± 23.69; 15.65 ± 4.7, respectively) • In participants with DM, IWL (mm/mm2) & ANFL (CNFL + IWL/2; mm/mm2) were also significantly reduced from baseline (24.69 ± 8.67; 23.26 ± 5.53, respectively) to FU (14.23 ± 6.13; 15.09 ± 4.48, respectively • Rate of annual decline in CNFL, IWL, & ANFL was significantly higher in patients with DM compared to controls • ICC showed good consistency between the changes per year in CNFL & IWL in participants with DM (ICC = 0.78; 95% confidence interval, 0.56–0.88) |
Ferdousi, et al.
78
-Compare the utility of quantifying corneal nerve loss at the inferior whorl & central cornea to QST & NCS in the diagnosis & assessment of DPN severity |
N = 143 n = 93 +DM n = 51 -DPN M = 57.68 ± 1.6 yrs/age n = 47 Mild DPN M = 60.16 ± 1.7 yrs/age n = 45 Moderate to severe DPN M = 64.1 ± 1.48 yrs/age |
• ROC curve & Youden index used to define optimum cutoff
points for CNFD, CNBD, CNFL, & IWL; CNFD AUC 0.71,
sensitivity 58%, & specificity 83%; CNBD AUC 0.70,
sensitivity 69%, & specificity 65%; CNFL AUC 0.68,
sensitivity 64%, & specificity 67%; IWL AUC 0.72,
sensitivity 70%, & specificity 65% • CNFD & CNBD were significantly lower in patients with -DPN (26.61 ± 1.05 & 64.07 ± 4.39, respectively) & mild DPN (24.47 ± 1.09 & 58.49 ± 4.76, respectively) compared to controls (33.71 ± 1.3 & 81.52 ± 5.54, respectively); CNFD & CNBD were significantly lower in patients with moderate to severe DPN (22.4 ± 1.14 & 45.60 ± 4.5, respectively) relative to those with -DPN & controls |
n = 30 Controls M = 54.51 ± 2.3 yrs/age Cross-sectional |
• CNFL & IWL were significantly lower in patients with
mild (20.84 ± 1.00 & 22.28 ± 1.31, respectively) &
moderate to severe (19.27 ± 1.04 & 19.03 ± 1.36,
respectively) DPN compared to controls (25.07 ± 1.27 &
31.69 ± 1.66, respectively); CNFL & IWL were
significantly lower in patients with moderate to severe DPN
relative to those with -DPN (23.31 ± 0.96 & 24.90 ±
1.26, respectively) • CCM identifies early & progressive corneal nerve loss at the inferior whorl & CC |
|
Ferdousi, et al.
103
-Assess the diagnostic utility of CCM for DPN & risk factors for corneal nerve loss |
N = 490 n = 149 T1D n = 269 T2D n = 72 HCs Cross-sectional |
• CNFD, CNBD, & CNFL were significantly reduced in
participants with T1D vs. those with T2D • ROC curve analysis for diagnosis DPN showed a very good AUC for CNFD at 0.81 with an optimal cutoff point of 29.40/mm2; sensitivity was 73.5% & specificity was 74.4% • ROC curve analysis for diagnosis DPN showed a reasonable AUC for CNBD at 0.74 with an optimal cutoff point of 64.58/mm2; sensitivity was 66.7% & specificity was 66.7% • ROC curve analysis for diagnosis DPN showed a reasonable AUC for CNFL at 0.73 with an optimal cutoff point of 24.00 mm/mm2; sensitivity was 66.7% & specificity was 66.4% • CCM identified more severe corneal nerve loss in T1D patients relative to those with T2D & shows very reasonable diagnostic accuracy for DPN |
Guimarães et al.
104
-Describe & validate an automatic approach to nerve tracing |
N = 30 n = 24 pathologic group n = 10 +DM n = 6 HCs Cross-sectional |
• Automatic nerve tracing, following a proposed algorithm,
was assessed with respect to manual grading of CNT (high,
mid, & low tortuosity classes) with a significant
Spearman’s rank correlation coefficient of 0.95
achieved • With setting 2 thresholds to distinguish between the 3 tortuosity classes, correct classification (93.3%) was yielded for the automatic compared to the manual approach • Nerve tracing results reveal the automatic method performed well although larger studies are needed to confirm results |
Kalteniece et al.
105
-Assess the effect of a standardized protocol for image selection & number of images required for adequate quantification of CN pathology using IVCCM |
N = 35 obese &/or
+DM M = 49.97 ± 12.47 yrs/age Longitudinal |
• In terms of inter-observer variability, ICC values for
CNFD, CNBD, & CNFL were significant at 0.93, 0.96, &
0.95, respectively • With respect to intra-observer variability, ICC values for CNFD, CNBD, & CNFL were significant at 0.95, 0.97, & 0.97, respectively • For sample size variability, ICC values for CNFD, CNBD, & CNFL were significant at 0.94, 0.95, & 0.96, respectively • Bland-Altman plots showed excellent agreement for all parameters • 6 images were found to be adequate for the fully automated analysis • Implementing a standardized protocol to select IVCCM images results in high intra- & inter-observer reproducibility for all corneal nerve parameters |
Lewis et al.106 -Determine reference distribution of annual CNFL change, prevalence of abnormal change in diabetes, & associated variables |
N = 794 n = 399 T1D M = 39.9 ± 18.7 yrs/age n= 191 T2D M = 60.4 ± 8.2 n = 204 Controls M = 37.9 ± 19.8 yrs/age Secondary analysis of longitudinal observational study |
• Participants with T1D (median FU of 3 visits over 4.4 yrs)
had a mean annual change in CNFL (mm/mm2) of
-0.8%; T1D participants with RCNFL had a significant annual
change in CNFL (-14.67 ± 11.46%) relative to T1D
participants without RCNFL (2.58 ±
9.93%) • Participants with T2D (median FU of 3 visits over 5.3 yrs) had a mean annual change in CNFL of -0.2%; T2D participants with RCNFL had a significant annual change in CNFL (-11.49 ± 6.35%) compared to T2D participants without RCNFL (2.47 ± 7.33%) • RCNFL prevalence was 17% overall & similar by DM type (16.0% T1D, 19.4% T2D) • RNCFL was significantly more frequent in those with baseline DSP (47%) vs. those without baseline DSP (30%) • RCNFL may identify patients at high risk for DSP development & progression |
Li et al.
107
-Examine & compare fully-automated & manually measured corneal nerve fiber parameters in T2D patients with & without DPN |
N = 152 n = 128 T2D n = 49 -DPN M = 67.12 ± 6.01 yrs/age n = 79 +DPN M = 70.15 ± 7.34 yrs/age n = 24 HCs M = 68.63 ± 5.19 yrs/age Cross sectional |
• CNFLM & CNBDM in +DPN group were
significantly lower than -DPN & HC
groups • Likewise, CNFLFA & CNBDFA in +DPN group were significantly reduced relative to -DPN & HC groups • CNFDFA, but not CNFDM, was significantly reduced in +DPN group vs. HC group • Significant, positive correlations between manual & fully automated CNFL, CNFD, & CNBD were observed • Fully automated method slightly underestimated corneal nerve fiber parameters. • A progressive decrease in manual & fully automated CNFL, CNBD & CNFD accompanied the occurrence of DPN • Fully automated corneal nerve fiber parameter quantification may be a fast, objective way to detect DPN |
Lovblom et al.
108
-Determine the predictive validity of a baseline IVCCM measure in identifying future DSP onset in patients with T1D |
N = 65 T1D, -DSP M = 34 ± 15 yrs/age Longitudinal (mean 3.5 years FU) |
• At FU, 54 (83%) remained without DSP & 11 (17%)
developed DSP • New-onset cases of DSP had lower baseline CNFL & CNBD but higher baseline CNFT • CNFL: AUC was 0.78; optimal operating threshold of 14.9 mm/mm2 with 82% sensitivity, 69% specificity, & 35% PPV • CNFT: AUC was 0.72; optimal operating threshold of 15.4 (tortuosity coefficient) with 73% sensitivity, 72% specificity, & 35% PPV • CNBD: AUC was 0.71; optimal operating threshold of 36.1 branches/mm2 with 82% sensitivity, 50% specificity, & 25% PPV • CNFL may have applicability in identifying high-risk patients for DSP |
Ostrovski et al.
109
-Determine inter- & intra-observer reproducibility of a novel automated analysis program vs. manual analysis |
N = 46 n = 26 T1D M = 42.8 ± 16.9 yrs/age n = 20 controls M = 41.4 ± 17.3 yrs/age |
• Inter-observer ICCs for CNFLM,
CNFLSA, & CNFLFA were 0.73,
0.75 & 0.78, respectively, with no significant
differences for 3-way comparisons; intra-observer ICCs were
0.72, 0.74, & 0.84, respectively, with CNFLFA
reproducibility significantly higher than that of
CNFLM & CNFLSA
• Inter-observer & intra-observer ICCs for CNFDM, CNFDSA, CNFDFA, CNBDM, CNBDSA, & CNBDFA were substantially lower compared to those for CNFL • Fully automated analysis preserves CNFL reproducibility despite an apparent measurement bias (underestimation) relative to the manual strategy of image analysis |
Perkins et al.
110
- Establish concurrent validity & diagnostic thresholds in a large cohort of participants with & without DSP |
N = 998 n = 516 T1D M = 42 ± 19 yrs/age n = 482 T2D M = 62 ± 10 yrs/age Cross-sectional, pooled multi-national consortium study |
• In participants with T1D, CNFLA had an AUC of
0.77 & optimal threshold of 12.5 mm/mm2 (73%
sensitivity & 69% specificity) • In participants with T2D, CNFLA had an AUC of 0.68 & optimal threshold of 12.3 mm/mm2 (69% sensitivity & 63% specificity) • In participants with T1D, AUC for CNBDA & CNFDA were 0.73 & 0.71, respectively • In participants with T2D, AUC for CNBDA & CNFDA were 0.66 & 0.52, respectively • In the total cohort, CNFLA had an AUC of 0.71 & optimal threshold of 12.3 mm/mm2 (67% sensitivity & 66% specificity); AUC of CNFLM (0.70) vs. CNFLA was marginally, yet significantly lower although its optimal threshold value of 16.3 mm/mm2 had similar operating characteristics • A lower CNFLA threshold value of <8.6 mm/mm2 to rule in DSP & upper CNFLA threshold value of 15.3 mm/mm2 to rule out DSP was associated with 88% specificity & 88% sensitivity • In the largest cohort to date, diagnostic validity & common diagnostic thresholds for CNFL in T1D & T2D established |
Petropoulos et al.
111
- Compare ability of CNFD, CNFL, & IWL alone & in combination for diagnosis of DPN |
N = 68 n = 53 +DM (T1D & T2D) n = 25 +DPN M = 60.1 ± 10.2 yrs/age n = 28 –DPN M = 42.4 ± 14.7 yrs/age n = 15 AMCs Cross-sectional |
• For diagnosis of DPN, ROC curve analysis showed CNFL =
21.9 mm/mm2 had an AUC of 0.75, sensitivity of
76%, & specificity of 65%; CNFD = 28.4
fibers/mm2 had an AUC of 0.74, sensitivity of
68%, & specificity of 61%; IWL = 20.0 mm/mm2
had an AUC of 0.70, sensitivity of 68%, & specificity of
67% • Combination of CNFL & IWL achieved an AUC of 0.75, sensitivity of 80%, & specificity of 71% for DPN • For inter & intra-observer agreement for IWL estimation, no significant difference between 2 separate observers (17.8 ± 8.5 vs. 17.7 ± 9.1 mm/mm2) & no significant difference (17.8 ± 8.5 vs. 17.2 ± 8.0 mm/mm2) when same observer assessed & reassessed IW center images from 1 dataset on 2 separate occasions • CNFD, CNFL, & IWL have comparable ability to diagnose DPN; combining IWL & CNFD may improve CCM diagnostic performance • Inter- & intra-observer agreement for IWL estimation was excellent |
Pritchard et al.
81
-Determine if deficits in CNFL assessed using CCM can predict future onset of DPN |
N = 90 T1D, -DPN (baseline) 4-yr FU n = 16 +DPN M = 51 ± 14 yrs/age (baseline) n = 64 -DPN M = 42 ± 16 yrs/age (baseline) Longitudinal |
• DPN developed in 16 participants (18%) after 4
yrs • Baseline CNFL (mm/mm2) predicted incident DPN at 4-yr FU • Participants who developed DPN at 4-yr FU had significantly lower baseline CNFL (14.0 ± 4.1) relative to participants (16.2 ± 3.5) who did not develop DPN • For CNFL, AUROC was 0.6 with a threshold cutoff of 14.1 mm/mm2; sensitivity was 63% & specificity was 74% to predict DPN • CCM may predict DPN in T1D |
Pritchard et al.
112
-Compare SNF damage in central cornea & whorl area in participants with DPN & examine accuracy of evaluating these 2 sites for DPN diagnosis |
N = 187 n = 107 T1D M = 48.3 ± 15.1 yrs/age n = 25 +DPN n = 82 -DPN n = 80 Controls M = 37.0 ± 17.8 yrs/age Cross-sectional |
• Participants with & without DPN had significantly
lower CNFLcenter compared to controls (14.2 ± 3.5
& 16.7 ± 3.5 mm/mm2 vs. 19.3 ± 3.0
mm/mm2, respectively) • Participants with & without DPN had significantly reduced CNFLwhorl relative to controls (15.4 ± 4.4 & 18.2 ± 3.9 mm/mm2 vs. 22.1 ± 3.9 mm/mm2, respectively) • For CNFLcenter, AUC was 0.76; Youden Index cutoff point of <17.9 with sensitivity of 90% & specificity of 50% for detecting DPN • For CNFLwhorl, AUC was 0.77; Youden Index cutoff point of <18.6 with sensitivity of 80% & specificity of 60% for detecting DPN • SNF pathology comparable at corneal central & whorl anatomical sites • Quantification of CNFL from the corneal center is as accurate as CNFL quantification of whorl area for diagnosis of DPN |
Scarpa et al.
113
- Investigate whether CNN can be successfully used for corneal nerve multiple-image analysis |
N = 100 participants, 600 confocal
images M = 53 ± 13 yrs/age n = 50 +DM (T1D & T2D), +DN n = 50 AMHCs Cross-sectional |
• Cross-validation used to evaluate a proposed algorithm for
binary classification (healthy or pathological) of 100
participants (CNN training on 80 subjects & evaluation
on the other 20, repeated 5 times) with 97% mean accuracy
for CNN correct classification • Also, with a final classification derived for each participant (properly classified if both right & left eyes correctly classified), CNN revealed validity with a mean accuracy of 96% • With outstanding classification accuracy, the CNN is a highly promising, fully automated method of corneal confocal image analysis with strong potential to yield improved results obtained from traditional methods |
Scarr et al.
114
-Evaluate agreement between manual & automated analysis protocols in controls & T1D & T2D participants with & without DSP |
N = 456 M = 53 ± 18 yrs/age n = 139 T1D n = 249 T2D n = 68 Controls Cross-sectional |
• For the study population, mean CNFLM (15.1 ±
4.9 mm/mm2) was greater than mean
CNFLA (10.5 ± 3.7 mm/mm2) although
values were highly correlated; absolute mean difference
between CNFLA & CNFLM for the
study population was -4.6 ± 2.6 mm/mm2 &
percentage difference was -29 ± 17%, representing
underestimation bias by CNFLA
• A similar pattern of correlations & underestimation bias was observed for CNFLM vs. CNFLA for T1D, T2D, & control groups • In participants with T1D, percentage difference between CNFLA & CNFLM for those with DSP was -27 ± 27%, & for those without DSP the percentage difference was -32 ± 13% although non-significantly • In participants with T2D, percentage difference between CNFLA & CNFLM for those with DSP was -28 ± 16%, & for those without DSP was -27 ± 16% although non-significantly • Weighted kappa statistic for agreement between tertiles of CNFLA & CNFLM was 0.62, indicating moderate to substantial agreement • CNFLA & CNFLM were significantly lower in T1D participants with DSP relative to those without DSP • CNFLA & CNFLM were not significantly lower in T2D participants with DSP compared to those without DSP • Although CNFLA underestimated CNFLM, its bias was non-differential between participant groups & its relationship with DSP status was preserved • Determination of diagnostic thresholds specific to CNFLA requires further investigation |
Schaldemose et al.
115
-Compare a new sampling method & AAC with established methods of corneal nerve quantification in patients with & without DSPN & HCs |
N = 88 n = 62 T1D n = 17 +DSPN M = 59 ± 11 yrs/age n = 45 -DSPN M = 44 ± 13 yrs/age n = 26 HCs M = 44 ± 15 yrs/age Cross-sectional |
• Using randomized & area adjusted method,
CNFDM & CNFLM were
significantly reduced in +DSPN group compared to both HC
& -DSPN groups; CNFLM values were larger in
-DSPN group relative to HCs • Using a randomized & area adjusted method, CNFDA, CNFLA &, CNBDA were reduced significantly in +DSPN & -DSPN groups compared to HCs & lowest in the +DSPN group • Randomized sampling & adjusted area method with automated analysis showed that, among +DSPN participants, CNFDA (no./mm2; 17.3 ± 12) had a higher mean than standard automated procedures (13.5 ± 9.1) with a significant difference of 28.1%; CNFLA (mm/mm2; 12.3 ± 6.8) had a higher mean than standard automated procedures (8.8 ± 4.7) with a significant difference of 39.8%%; CNBDA (no./mm2; 19.1 ± 14) had a higher mean than standard automated procedures (15.4 ± 12) with a significant difference of 24.0% • Randomized sampling & adjusted area method with automated analysis showed that, among -DSPN participants, CNFDA (no./mm2; 28.2 ± 9.3) had a higher mean than standard automated procedures (22.6 ± 7.3) with a significant difference of 24.8%; CNFLA (mm/mm2; 17.0 ± 4.2) had a higher mean than standard automated procedures (13.4 ± 3.3) with a significant difference of 26.9%%; CNBDA (no./mm2; 31.1 ± 18) had a higher mean than standard automated procedures (26.2 ± 15) with a significant difference of 18.7% • Interobserver reliability testing revealed no significant difference in means for CNFLM, CNFDM, & CNBDM between the investigator & a blinded second observer • Randomized sampling method & area-dependent analysis objectively shows a reduction in corneal nerve parameters in diabetic patients with & without DSPN while providing unbiased corneal nerve quantification |
Tummanapalli et al.
116
- Determine utility of CCM & tear neuromediator analysis in diagnosis of DPN |
N = 70 n = 38 T1D n = 19 +DPN M = 44 ± 12 age/yrs n = 19 -DPN M = 37 ± 10 age/yrs n = 32 T2D n = 16 +DPN M = 58 ± 6 age/yrs n = 16 -DPN M = 52 ± 12 age/yrs Prospective, cross- sectional |
• For DPN diagnosis in T1D, IWL had the best diagnostic
performance (AUC 0.91, optimal diagnostic threshold of
≤12.93 mm/mm2, 89% sensitivity, & 83%
specificity), followed by CNFrD (AUC 0.89; diagnostic
threshold ≤1.50, 89% sensitivity, & 72% specificity),
CNFD (AUC 0.88, diagnostic threshold ≤22.46
no./mm2, 83% sensitivity, & 83%
specificity), IWNFrD (AUC 0.88, diagnostic threshold ≤1.46,
83% sensitivity, & 89% specificity), CNFL (AUC 0.87,
diagnostic threshold ≤14.24 mm/mm2, 89%
sensitivity, & 78% specificity), CNBD (AUC 0.76,
diagnostic threshold ≤26.17 no./mm2, 72%
sensitivity, & 72% specificity), & CTBD (AUC 0.75,
diagnostic threshold ≤40.40 no./mm2, 72%
sensitivity, & 72% specificity) • For DPN diagnosis in T2D, CNFL had the best diagnostic performance (AUC 0.81, optimal diagnostic threshold ≤13.64 mm/mm2, 81% sensitivity, & 81% specificity), followed by CNFrD (AUC 0.78, diagnostic threshold ≤1.48, 75% sensitivity, & 63% specificity), CNBD (AUC 0.76, diagnostic threshold ≤29.17 no./mm2, 81% sensitivity, & 75% specificity) CNFD (AUC 0.76, diagnostic threshold ≤22.90 no./mm2, 75% sensitivity, & 69% specificity), CTBD (AUC 0.76, diagnostic threshold ≤43.10 no./mm2, 81% sensitivity, & 81% specificity), & IWNFrD (AUC 0.73, diagnostic threshold ≤1.47, 69% sensitivity, & 62% specificity) • In T1D & T2D, different corneal nerve parameters were identified, suggesting different disease processes across conditions |
Wang et al.
117
-Explore the application of CCM in DPN & other T2D chronic complications |
N = 220 n = 100 T2D +DPN M= 56.2 ± 12.4 age/yrs n = 72 -DPN M = 54.9 ± 11.1 age/yrs n = 37 T2D +DN n = 89 T2D +DR n = 48 HCs M = 51.9 ± 14.9 yrs/age Cross-sectional |
• In participants with T2D, CNFL & CNBD were
significantly lower than HCs, & similar in +DPN group
compared to -DPN group • Using CCM to identify DPN, AUC for CNFD was 0.67 & optimal cutoff was 24.68 no./mm2 (78% sensitivity, 53% specificity); AUC for CNFL was 0.70 & optimal cutoff was 15.32 mm/mm2 (80% sensitivity, 60% specificity); AUC for CNBD was 0.68 & optimal cutoff was 39.0 no./mm2 (85% sensitivity, 47% specificity) • This study provides more support for clinical use of CCM to diagnose DPN |
Williams et al.
118
-Validate a DLA for corneal nerve segmentation in CCM images & compare to the widely used, validated automated image analysis software, ACCMetrics |
N = 3865 confocal images of corneal SBP
obtained from +DM individuals & HCs n = 120 confocal images from Italy n = 1578 confocal images from China n = 2137 confocal images from UK |
• DLA, employing CNN with data augmentation, trained using a
high-end graphics processor unit on 1698 images for
automated quantification of the corneal SBP for DN
diagnosis • DLA further tested on 2137 images for external validation with DLA ICCs superior to those for ACCMetrics for total CNFL (0.93 vs. 0.83), mean length per segment (0.66 vs. 0.33), number of branch points (0.89 vs 0.57), number of tail points (0.62 vs. 0.26), number of nerve segments (0.88 vs. 0.50) & fractals (0.93 vs 0.76) • DLA achieved an AUC of 0.83, specificity of 0.87, & sensitivity of 0.68 for the classification of participants without (n = 90) or with (n = 132) neuropathy • Results reveal DLA provides rapid & excellent localization performance for quantification of corneal nerve biomarkers • DLA model has potential for adoption into clinical screening programs for DN |
Abbreviations: AAC, adjusted area calculation; ACNBD, automated corneal nerve branch density; ACNFD, automated corneal nerve fiber density; ACNFL, automated corneal nerve fiber length; ACNFrD, automated corneal nerve fiber fractal dimension; AMC, age-matched controls; AMHCs, age-matched healthy controls; ANFL, average nerve fiber length; AUC, area under the curve; AUROC, area under the receiver operator characteristic; BD, beading density; CC, central cornea; CCM, corneal confocal microscopy; CG, control group; CN, corneal nerve; CNBD, corneal nerve branch density; CNBDA, corneal nerve branch density with automated analysis; CNBDFA, corneal nerve branch density with fully automated analysis; CNBDM, corneal nerve branch density with manual analysis; CNBDSA, corneal nerve branch density with semi-automated analysis; CNFD, corneal nerve fiber density; CNFDA, corneal nerve fiber density with automated analysis; CNFDFA, corneal nerve fiber density with fully automated analysis; CNFDM, corneal nerve fiber density with manual analysis; CNFDSA, corneal nerve fiber density with semi-automated analysis; CNFL, corneal nerve fiber length; CNFLA, corneal nerve fiber length with automated analysis; CNFLcenter, corneal nerve fiber length at the central cornea; CNFLFA, corneal nerve fiber length with fully automated analysis; CNFLM, corneal nerve fiber length with manual analysis; CNFLSA, corneal nerve fiber length with semi-automated analysis; CNFLwhorl, corneal nerve fiber length at the whorl; CNFrD, corneal nerve fractal dimension; CNFT, corneal nerve fiber tortuosity; CNL, corneal nerve length; CNM, corneal nerve migration; CNN, convolutional neural network; CNT, corneal nerve thickness or corneal nerve tortuosity; CSNP, corneal sub-basal nerve plexus; CTBD, corneal total branch density; DLA, deep learning algorithm; DM, diabetes mellitus; DN, diabetes neuropathy; DPN, diabetes peripheral neuropathy; DSP, diabetic sensorimotor polyneuropathy or distal symmetric polyneuropathy; DSPN, diabetes symmetrical peripheral neuropathy or diabetic sensorimotor polyneuropathy; EEP, equal error point; EER, equal error rate; EERP, equal error rate point; FU, follow-up; HCs, healthy controls; ICC, interclass correlation coefficient; IENFD, intraepidermal nerve fiber density; IGT, impaired glucose tolerance; IVCCM, in vivo corneal confocal microscopy; IWL, inferior whorl length; IWNFrD, inferior whorl nerve fractal dimension; M, mean; MCNBD, manual corneal nerve branch density; MCNFD, manual corneal nerve fiber density; MCNFL, manual corneal nerve fiber length; MDL, mean dendric length; MFU, mean follow-up; mm, millimeter; mm/mm2, millimeter/square millimeter; mm2, millimeters squared; NBD, nerve branch density; NBe, number of beadings; NBi, number of bifurcations; NBr, number of branches; NCs, normal controls; NDS, Neuropathy Disability Score; NFA FIJI, nerve fiber area determined by total number of pixels within the nerve plexus; NFA W×L, nerve fiber area determined by length times average width; NFD, nerve fiber density; NFL, nerve fiber length; NFLD, nerve fiber length density; NFT, nerve fiber tortuosity; NGT, normal glucose tolerance; no., number; no./mm2, number/square millimeter; NSP, Neuropathy Symptom Profile,; NT, number of trunks; PN, peripheral neuropathy; PNCV, peroneal nerve conduction velocity; PPV, positive predictive value; QST, quantitative sensory testing; RCNFL, rapid corneal nerve fiber loss; RNFL, retinal nerve fiber layer; ROC, receiver operator characteristic; S/S, sensitivity/specificity; SBP, sub-basal nerve plexus; SCNP, sub-basal corneal nerve plexus; SD, standard deviation; SD-OCT, spectral domain optical coherence tomography; SNF, small nerve fiber; T1D, type 1 diabetes; T2D, type 2 diabetes; VPT, vibration perception threshold; vs., versus; WST, warm sensation threshold; yr, year; yrs, years; μm2, square micrometer.